Procept BioRobotics Corp (PRCT): Next-Year EPS Estimate 27.66%
As of 2026-11-12, Procept BioRobotics Corp (PRCT) has a next-year EPS growth estimate of 27.66%. Featured in our EPS revision report on 2026-10-12.
On 2026-11-11, analyst consensus for PRCT's next-year EPS growth shifted from 28.68% to 27.66% — a negative change of 1.02 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at -0.04%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 27.66%
- EPS growth this year
- -0.04%
- EPS next quarter (est)
- -$0.23
- Last price
- $23.51
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 27.66% | -0.04% | -$0.23 | $23.51 |
| 2026-11-11 | 27.66% | -0.04% | -$0.23 | $23.34 |
| 2026-11-10 | 28.68% | 0.16% | -$0.23 | $23.05 |
| 2026-11-09 | 28.98% | 0.11% | -$0.23 | $22.37 |
| 2026-11-07 | 28.98% | 0.11% | -$0.23 | $20.62 |
| 2026-11-06 | 28.98% | 0.11% | -$0.23 | $20.62 |
| 2026-11-05 | 28.98% | 0.11% | -$0.23 | $20.27 |
| 2026-11-04 | 31.13% | 2.77% | -$0.39 | $21.66 |
| 2026-11-03 | 31.13% | 2.77% | -$0.39 | $20.17 |
| 2026-11-02 | 31.13% | 2.77% | -$0.39 | $19.44 |
| 2026-10-31 | 31.13% | 2.77% | -$0.39 | $19.20 |
| 2026-10-30 | 31.13% | 2.77% | -$0.39 | $19.20 |
| 2026-10-29 | 31.13% | 2.77% | -$0.39 | $20.30 |
| 2026-10-28 | 31.13% | 2.77% | -$0.39 | $20.20 |
| 2026-10-27 | 31.13% | 2.77% | -$0.39 | $19.80 |
| 2026-10-26 | 31.13% | 2.77% | -$0.39 | $19.83 |
| 2026-10-23 | 31.13% | 2.77% | -$0.39 | $19.96 |
| 2026-10-22 | 31.13% | 2.77% | -$0.39 | $20.03 |
| 2026-10-21 | 31.13% | 2.77% | -$0.39 | $18.27 |
| 2026-10-20 | 31.13% | 2.77% | -$0.39 | $18.82 |
| 2026-10-19 | 31.13% | 2.77% | -$0.39 | $18.28 |
| 2026-10-16 | 31.13% | 2.77% | -$0.39 | $17.57 |
| 2026-10-15 | 31.13% | 2.77% | -$0.39 | $18.15 |
| 2026-10-14 | 31.13% | 2.77% | -$0.39 | $17.51 |
| 2026-10-13 | 31.13% | 2.77% | -$0.39 | $19.10 |
| 2026-10-12 | 31.13% | 2.77% | -$0.39 | $19.57 |
| 2026-10-11 | 31.14% | 2.77% | -$0.39 | $18.40 |
| 2026-10-10 | 31.14% | 2.77% | -$0.39 | $18.40 |
| 2026-10-09 | 31.14% | 2.77% | -$0.39 | $18.40 |
| 2026-10-08 | 31.10% | 2.77% | -$0.39 | $17.90 |
Reports Featuring PRCT
Recent News
- Kaplan Fox Encourages PROCEPT BioRobotics Corporation (PRCT) Investors Who Suffered Losses to Seek a Leadership Role Before September 22, 2026Newsfile
- PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & JuneGlobeNewswire
- PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...GuruFocus.com
- PROCEPT BioRobotics Reports First Quarter 2026 Financial ResultsGlobeNewswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Procept BioRobotics Corp's next-year EPS growth estimate?▾
As of 2026-11-12, Procept BioRobotics Corp (PRCT) has a next-year EPS growth estimate of 27.66%, based on analyst consensus.
When was the latest EPS estimate revision for PRCT?▾
The most recent revision occurred on 2026-11-11, when analysts adjusted the next-year EPS growth estimate from 28.68% to 27.66%.
What sector and industry does Procept BioRobotics Corp belong to?▾
Procept BioRobotics Corp operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PRCT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Procept BioRobotics Corp (PRCT) appears here because it was detected by our daily top-EPS-revision-performer screen.